Skip to Content
HubMed
  • Solutions
    • Overview
    • Medea™
    • Adam™
  • Industries
    • Overview
    • Nutraceuticals
    • Cosmetics
    • Medical Devices
    • Contract Research Organization
  • Why Hubmed™
    • Overview
    • Swiss made quality
    • Data security
    • AI-Assisted
    • PICO Framework
    • End-to-End Integration
  • Resources
    • Blog
    • Press Room
    • Medea™ | Early Adopter Program
    • Medea™ | Referral Program
    • Medea™ | CER Maintenance Calculator
    • Medea™ | ROI & Savings
  • About Us
  • Contact Us 
HubMed
      • Solutions
        • Overview
        • Medea™
        • Adam™
      • Industries
        • Overview
        • Nutraceuticals
        • Cosmetics
        • Medical Devices
        • Contract Research Organization
      • Why Hubmed™
        • Overview
        • Swiss made quality
        • Data security
        • AI-Assisted
        • PICO Framework
        • End-to-End Integration
      • Resources
        • Blog
        • Press Room
        • Medea™ | Early Adopter Program
        • Medea™ | Referral Program
        • Medea™ | CER Maintenance Calculator
        • Medea™ | ROI & Savings
      • About Us
    • Contact Us 

    HubMed™ Press Room 

    Stay updated with our latest corporate announcements, product launches, and media coverage.

    Official Press Releases

     

    Media Relations


    For press inquiries, interview requests with our founders, or technical commentary on Life Sciences AI, please contact our PR team:

    • Email: press@hubmed.ch
    • Location: Lugano, Switzerland

    Media Kit


    Download official brand assets, leadership bios, and product screenshots approved for publication.

    • 📁 HubMed™ Official Logos (ZIP, High-Res)
    • 📄 Medea™ Product Fact Sheet
    • 👤 Executive Leadership Bios

    October 6, 2026


    HubMed Introduces an AI-Assisted Approach to Regulatory Compliance

    At CPHI Milan (6–8 October), HubMed presents Medea™, the AI-assisted workspace for EU MDR clinical evaluation that keeps qualified experts in control of every decision. The media kit includes a fact sheet, a spokesperson quote and boilerplates.

    Read More →

    September 14, 2026


    HubMed Acting CEO Amedeo Chiappini to Speak on Regulatory Scaling at CPHI Milan

    Featured on the Supply & Formulation Excellence Stage on October 8th, Amedeo Chiappini will discuss how AI-assisted scientific appraisal helps health brands navigate regulatory scrutiny and eliminate supply chain bottlenecks.

    Read More →

    August 3, 2026


    HubMed at CPHI Milan: Experience the Future of AI-Assisted Regulatory & Scientific Compliance Live

    HubMed is taking the stage at CPHI Milan as an Official Sponsor. Join us at Stand 8S114 (Start-Up Market Zone) for interactive demos of Medea™ for EU MDR compliance, and catch our panel session on nutraceutical supply and regulatory scrutiny.

    Read More →

    June 21, 2026


    HubMed Launches Medea™: The First AI-Powered Clinical Evaluation Platform Purpose-Built for EU MDR Compliance

    Commercial rollout of Medea™ begins today, empowering CROs and medical device manufacturers to cut clinical evaluation timelines by up to 70% while securing an immediate, measurable financial return amid unprecedented regulatory pressure.

    Read Full Release →

    USEFUL LINKS
    • Home
    • Solutions
    • Industries
    • Why Hubmed™
    • About us
      Privacy Policy
    • Contact us
    ABOUT US

    HubMed™ is a Swiss-made, AI-assisted platform for Life Sciences R&D and regulatory compliance, connecting preclinical discovery (Adam™) with clinical evaluation under EU MDR (Medea™). 

    It accelerates research-intensive work — literature search, screening, appraisal and structured drafting — while qualified experts stay in control of every scientific and regulatory decision.

    CONNECT WITH US
    • Contact us
    • info@hubmed.ch

    Follow us
    2026 Copyright © HubMed™ Technologies GmbH  |  Accelerating Discovery, Ensuring Compliance
    Powered by Odoo - Create a free website